MEI Pharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 15   

Articles published

MEIP 7.26 +0.02 (0.28%)
price chart
Dr. Daniel Gold, President and CEO of MEI Pharma Inc (MEIP), Presents at ...
Dr. Daniel Gold, President & CEO of MEI Pharma Inc (MEIP), updated investors on the status of research involving the company's three wholly owned drug candidates: Pracinostat, ME-344 and PWT143.
MEI Pharma To Present At Wedbush PacGrow Life Sciences And Canaccord ...
SAN DIEGO, Aug. 6, 2014 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel P. Gold, Ph.
Related articles »  
Trader's Watch List : NVIDIA Corporation (NASDAQ:NVDA), Zynga (NASDAQ ...
Genomic Health Inc. (NASDAQ:GHDX) price to sales (P/S) ratio is 3.21. On 15 August MEI Pharma, Inc. (NASDAQ:MEIP) ended the day at $6.69.
Related articles »  
Best Stocks: Yingli Green Energy (NYSE:YGE), Nokia Corporation (ADR) (NYSE ...
MEI Pharma, Inc. (NASDAQ:MEIP)'s stock on 19 August moved up 1.20% to the closing price of $6.77. Its fifty two weeks range is $5.51 - 13.98.
Big Movers: Citigroup Inc. (NYSE:C), Gilead Sciences Inc. (NASDAQ:GILD ...
Investment analysts at Brean Capital started coverage on shares of MEI Pharma (NASDAQ:MEIP) in a note issued to investors on Tuesday July 10.
Wedbush PacGrow Life Sciences Hosts Management Access Conference, Offers ...
The conference connects institutional investors with management executives from prominent public and private companies specializing in emerging pharmaceuticals, biotechnology, biopharmaceuticals, biodefense, medical device and medical diagnostics ...
Related articles »